improvements in biotechnology are revolutionizing pores and skin regeneration, offering new hope for managing wounds, injuries, and cosmetic skin treatment. A crucial innovation in this subject is Recombinant Human Epidermal development component (rhEGF), a complicated solution with huge potential for advertising and marketing skin recovery and cel